Polydex Pharmaceuticals Issues First Quarter Financial Results
15 juin 2023 08h30 HE
|
Polydex Pharmaceuticals Limited
TORONTO, June 15, 2023 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) reports financial results for the first quarter of fiscal 2024, the period ended April...
Intravenous Iron Drugs Global Market Report 2023: Upsurge in Chronic Renal Disease Bolsters Demand
17 mai 2023 06h28 HE
|
Research and Markets
Dublin, May 17, 2023 (GLOBE NEWSWIRE) -- The "Intravenous Iron Drugs Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented By Application (Intestinal...
Polydex Pharmaceuticals Issues Year End Financial Results
01 mai 2023 15h56 HE
|
Polydex Pharmaceuticals Limited
TORONTO, May 01, 2023 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) reports financial results for its fiscal year ended January 31, 2023. All figures are...
Polydex Pharmaceuticals Limited and BioSpectra Inc. Announce Business Combination
27 avr. 2023 13h40 HE
|
Polydex Pharmaceuticals Limited
TORONTO, April 27, 2023 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC Pink: POLXF) (the “Company” or “Polydex”) announced today that it has entered into a Plan of Arrangement agreement...
Polydex Pharmaceuticals Issues Third Quarter Financial Results
15 déc. 2022 09h00 HE
|
Polydex Pharmaceuticals Limited
TORONTO, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC Pink: POLXF) (the “Company”) reports financial results for the third quarter of fiscal 2023, the period ended...
Polydex Pharmaceuticals Issues First Quarter Financial Results
15 juin 2022 08h45 HE
|
Polydex Pharmaceuticals Limited
TORONTO, June 15, 2022 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) reports financial results for the first quarter of fiscal 2023, the period ended April...
Polydex Pharmaceuticals Issues Year End Financial Results
02 mai 2022 09h58 HE
|
Polydex Pharmaceuticals Limited
TORONTO, May 02, 2022 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) reports financial results for its fiscal year ended January 31, 2022. All figures are...
Polydex Pharmaceuticals Announces Collaboration with Termanox Water Treatment Solutions for novel use of Native Dextran
26 janv. 2022 08h40 HE
|
Polydex Pharmaceuticals Limited
TORONTO, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) is pleased to announce that it has entered into an agreement with Termanox Water...
Polydex Pharmaceuticals Issues Third Quarter Financial Results
15 déc. 2021 10h55 HE
|
Polydex Pharmaceuticals Limited
TORONTO, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC Pink: POLXF) (the “Company”) reports financial results for the third quarter of fiscal 2022, the period ended October...
Polydex Pharmaceuticals Issues Second Quarter Financial Results
15 sept. 2021 08h30 HE
|
Polydex Pharmaceuticals Limited
TORONTO, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC Pink: POLXF) (the “Company”) reports financial results for the second quarter of fiscal 2022, the period ended July...